InvestorsHub Logo
icon url

Tuff-Stuff

05/02/13 12:01 PM

#507896 RE: Tuff-Stuff #507895

AVEO PHARMACEUTICALS HAS NOT DEMONSTRATED A FAVORABLE BENEFIT TO RISK PROFILE FOR ITS KIDNEY CANCER DRUG IN AN ADEQUATE, WELL-CONTROLLED TRIAL
icon url

BUBBA

05/02/13 12:02 PM

#507897 RE: Tuff-Stuff #507895

VISA CALLs!! Well my gut said buy but my brain said no. I shoulda listened to my gut. Could have gotten over 100% still. Probably be over $180 when I get back this time.